Mainly because AIs dramatically decrease the estrogen amount in women following menopause, they might also trigger bone thinning, at times resulting in osteoporosis and in many cases fractures. Development taking place 6 or maybe more months following initiating the 1st endocrine therapy for metastatic disease (possibly fulvestrant or aromatase inhibitor https://hallajx555zhn6.laowaiblog.com/profile